CorVista System with PH Add-On vs 1CMR Pro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CorVista Health
VS
by Mycardium AI Limited

AI Verdict

Tool A offers a non-invasive, point-of-care diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension by analyzing cardiac and hemodynamic signals. In contrast, Tool B is an AI-enhanced reporting software specifically designed to improve the speed and precision of analyzing existing Cardiac MRI images. While both are cardiology AI solutions, they serve different functions within the diagnostic pathway and utilize distinct data modalities.

Choose CorVista System with PH Add-On if…

Choose CorVista System with PH Add-On if your primary need is a rapid, non-invasive, point-of-care diagnostic solution for early assessment of coronary artery disease and pulmonary hypertension. This system is ideal for situations requiring quick results without radiation, contrast agents, or extensive patient preparation, enabling immediate insights into cardiac and hemodynamic signals directly at the patient's bedside.

View CorVista System with PH Add-On →

Choose 1CMR Pro if…

Choose 1CMR Pro if your institution already performs Cardiac MRI scans and seeks to significantly enhance the precision, consistency, and speed of your cardiac MRI reporting workflow. This AI-enhanced software is best suited for optimizing the analysis of existing CMR images, providing automated and highly accurate volumetric and functional measurements with local data processing to maintain institutional control over patient data.

View 1CMR Pro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CorVista System with PH Add-On 1CMR Pro
Pricing Unknown Contact for pricing
Deployment Cloud-based, point-of-care system. On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform)
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CorVista System with PH Add-On

Tool A (CorVista System) offers a non-invasive, point-of-care diagnostic solution that requires no radiation, contrast agents, injections, fasting, or exercise, providing rapid results within minutes. This significantly reduces patient burden and simplifies the diagnostic workflow compared to the more complex Cardiac MRI procedure enhanced by Tool B.

Clinical Value

1CMR Pro

While both tools are FDA-cleared, Tool B (1CMR Pro) explicitly claims to deliver up to 40% more precise measurements and faster, more consistent cardiac MRI analysis. This quantifiable improvement in precision for an established, detailed diagnostic modality offers a strong clinical value proposition by enhancing the accuracy and reproducibility of critical cardiac assessments.

Pricing & Value

Tie

Both tools state 'contact for pricing' and do not publicly disclose their pricing models. Without specific cost information or detailed return on investment studies, it is impossible to accurately compare their pricing and overall value proposition.

Enterprise Readiness

1CMR Pro

Tool B (1CMR Pro) offers on-premise deployment with local data processing, ensuring no patient data is transmitted beyond the institution, and holds ISO 27001 certification. This provides a higher degree of data control and security, which is often preferred by large healthcare enterprises with stringent data governance requirements, compared to Tool A's cloud-based deployment and 'likely' HIPAA compliance.

Innovation

CorVista System with PH Add-On

Tool A (CorVista System) introduces a pioneering non-invasive, point-of-care AI diagnostic platform for cardiovascular diseases, eliminating traditional requirements like radiation or injections. This represents a more disruptive innovation by offering a fundamentally new approach to diagnosis, rather than enhancing an existing imaging modality.

Support & Docs

Tie

Both companies provide general contact information for support, and FDA documentation for both products mentions 'Instructions for Use' or 'usability engineering'. However, neither the provided facts nor web searches offer sufficient detail to differentiate the quality, accessibility, or comprehensiveness of their support and documentation offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CorVista System with PH Add-On 1CMR Pro
Name CorVista System with PH Add-On 1CMR Pro
Company Analytics for Life Mycardium AI Limited
Description The CorVista System with PH Add-On is an FDA-cleared, non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease and pulmonary hypertension using machine-learned algorithms. 1CMR Pro by Mycardium AI is an FDA 510(k) cleared and CE Class IIB cleared AI-enhanced Cardiac MRI reporting software that delivers up to 40% more precise measurements, enabling faster and more consistent cardiac MRI analysis.
Key Features Non-invasive cardiovascular diagnostics, Point-of-care testing, Machine-learned algorithms for analysis, Analyzes cardiac and hemodynamic signals, No radiation, contrast agents, injections, fasting, or exercise required, Rapid results available within minutes, Secure web portal for physician access to analysis, Modular design with disease-specific add-ons (CAD, PH) AI-enhanced Cardiac MRI Reporting, Automated volumetric and functional measurements, Convolutional neural networks trained on extensive datasets (700,000 cine images, 60,000 expert segmentations), Local data processing (no patient data transmitted beyond institution), Transparent and editable contours for clinician control, Regulatory-grade automation for enhanced precision and reproducibility, Achieves up to 40% higher precision than manual analysis, Validated across multi-centre datasets
Specialties Cardiology, Internal Medicine, Pulmonology Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring CorVista System with PH Add-On and 1CMR Pro.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CorVista System with PH Add-On is a non-invasive, point-of-care AI diagnostic platform for rapid assessment of coronary artery disease (CAD) and pulmonary hypertension (PH), requiring no radiation, contrast agents, injections, fasting, or exercise. In contrast, 1CMR Pro is an AI-enhanced Cardiac MRI reporting software that delivers up to 40% more precise measurements, enabling faster and more consistent analysis of existing Cardiac MRI scans.
The CorVista System provides rapid results within minutes, available via a secure web portal, making it suitable for point-of-care initial assessments. 1CMR Pro enhances the reporting phase of Cardiac MRI, enabling faster and more consistent analysis post-scan, and aims to improve precision and reproducibility.
The CorVista System with PH Add-On primarily benefits Cardiology, Internal Medicine, and Pulmonology due to its focus on non-invasive assessment of coronary artery disease and pulmonary hypertension. 1CMR Pro is designed for Cardiology and Radiology, as it directly enhances the analysis and reporting of Cardiac MRI studies.
The CorVista System is non-invasive and requires no radiation, contrast agents, injections, fasting, or exercise, offering a low-burden option for patients. 1CMR Pro integrates with existing Cardiac MRI workflows, meaning it requires patients to undergo a Cardiac MRI scan, and the software is installed on the hospital's own computer.
AI Tool Finder
AI-powered search. Results may not be comprehensive.